ID=H0817
URL=http://www.bioweb.ch/en/guides/legislation/06
SIZE=7273
DATE=11/07/2002
TIME=17:08:18
DATASET=Biology
HTML=<!DOCTYPE HTML PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN">
<html lang="en">

<head>
	<title>Bioweb - International Treaties</title>
	<meta http-equiv="Content-Type" content="text/html; charset=iso-8859-1">
	<meta name="description" content="In the domain of gene-technology individual states as well as the European Union have regulations of their own. Most of them strive to cover the domain as comprehensibly as possible without limiting research and economic production unnecessarily.">
	<meta name="keywords" content="Legislation, Controls">
	<meta name="author" content="Eveline Lecoq">
	<meta name="copyright" content="BICS">
	<link rel="stylesheet" href="/screen.css" type="text/css">
</head>

<body>
<table border="0" cellpadding="3" cellspacing="0" width="100%">
	<tr>
		<td class="logo">BIOWEB.CH <font color="#CCCCCC">BIOTECHNOLOGY INFORMATION</font></td>
		<td>&nbsp;</td>
	</tr>
	<tr>
		<td class="navbar"><a class="navbar" href="/en/">Home</a> | <a class="navbar" href="/en/topics">Topics</a> | <a class="navbar" href="/en/news">News</a> | <a class="active" href="/en/articles">Publications</a> | <a class="navbar" href="/en/library">Library</a> | <a class="navbar" href="/en/links">Links</a> | <a class="navbar" href="/en/agenda">Agenda</a> | <a class="navbar" href="/en/glossary">Glossary</a> | <a class="navbar" href="/en/feedback">Feedback</a> | <a class="navbar" href="/en/search">Search</a> | <a class="navbar" href="/en/about">About</a>&nbsp;</td>
		<td align="right" class="navbar">&nbsp;[<a class="navbar" href="/de/guides/legislation/06">de</a>] [<a class="navbar" href="/fr/guides/legislation/06">fr</a>] </td>
	</tr>
</table>
		<table border="0" cellpadding="20" cellspacing="0" width="100%">
			<tr>
				<td width="25%" valign="top" class="side">
					<img src="/logo.gif" alt="">
				</td>
				<td width="75%" valign="top">
					<h1>International Treaties</h1>
					<p class="description"><strong>In the domain of gene-technology individual states as well as the European Union have regulations of their own. Most of them strive to cover the domain as comprehensibly as possible without limiting research and economic production unnecessarily.</strong></p>
				</td>
			</tr>

			<tr>
				<td width="25%" valign="top" class="side"> &nbsp;</td>
				<td width="75%" valign="top">
			<p>Essentially, all regulations aim towards the protection of human life and health. The dignity of animals is specifically considered only in <a href="http://www.evd.admin.ch/archived/dm/DM_4_GENTECHNOLOGIE__11_11_98_/D/QUESTIONS__REPONSES/6-Gesetzgebung.htm">Swiss legislation</a>.</p>
			<p>Since 1992 efforts to find international solutions in the areas of biodiversity, biological safety, bioethics and intellectual property have been boosted by the increasing perception of the need for sustainable environmental development and by the globalisation of exchange and trade in the field of biotechnology. Many governments and international organisations, such as the United Nations Organisation (<a href="http://www.un.org/">UNO</a>, <a href="http://www.unido.org/">UNIDO</a>, 
			<a href="http://www.unep.org/">UNEP</a>, <a href="http://www.unesco.org/">UNESCO</a>), the <a href="http://www.wipo.int/">World Intellectuel Property Organisation (WIPO)</a> and even the <a href="http://www.wto.org/">World Trade Organisations (WTO/GATT)</a>, participated in the negotiations which resulted in various international treaties and conventions.</p>
		</td>
			</tr>
			
			<tr>
				<td width="25%" valign="top" class="side"> &nbsp;</td>
				<td width="75%" valign="top">
			
			<h2>Biodiversity</h2>
			
			<p>In 1992 the <a 
			href="http://www.biodiv.org/chm/conv/cbd_text_e.htm">Convention 
			on Biodiversity</a> was agreed upon at the same time as the 
			Convention on Climate in Rio de Janeiro(Brazil). The aims were: 
			the conservation of biological diversity, the sustainable use 
			of its elements and a fair and equal distribution of the 
			scientific, technological and economic profits yielded by the 
			genetic ressources.</p>
			
			<p>From January 24 to 28, 2000, <a href="http://www.uvek.admin.ch/doku/presse/1998/d/99021704.htm">members of governments from all over the world met in Montreal</a> where they succeeded reaching a consensus: the Protocol of Cartagena.</p>
		
		</td>
			</tr>
			
			<tr>
				<td width="25%" valign="top" class="side"> &nbsp;</td>
				<td width="75%" valign="top">
			<h2>Biological Safety</h2>
			<p>So far biological safety has mainly been regulated on a national level and otherwise, internationally, within the <a href="http://www.uvek.admin.ch/doku/presse/1998/d/99021704.htm">Protocol of Cartagena</a>. This protocol allows the trade and the international transport of GMOs and indirectly furthers the adaptation of national legislations to these regulations.</p>
			<p>The importance of biological safety will increase in the next few years, especially in the context of food containing GMO and in the context of biological weapons.</p>
		</td>
			</tr>
			
			<tr>
				<td width="25%" valign="top" class="side"> &nbsp;</td>
				<td width="75%" valign="top">
			<h2>Bioethics</h2>
			<p>The <a href="http://www.unesco.org/">UNESCO</a> has appointed an <a href="http://www.unesco.org/ibc/">International Bioethics Committee</a>. This reflects the increasing importance of ethical issues brought on by the impact of the rapid development of scientific knowledge on society and culture generally. 
The Bioethics Committee will formulate new ethical criteria in the domain of gene-technology in order to provide decision-makers with criteria that go beyond economic considerations.</p>
		</td>
			</tr>
			
			<tr>
				<td width="25%" valign="top" class="side"> &nbsp;</td>
				<td width="75%" valign="top">
			<h2>Intellectual Property</h2>
			<p>The <a href="http://www.wipo.int/">WIPO</a> has appointed a work-group with the objective of elaborating new regulations in the domain of biotechnology. A general procedure for granting patents on biotechnological inventions has to be defined. The interaction of these patents with those of other domains has to be clarified. In addition, the moral and ethical aspects of commercialising inventions based on genetically modified plants and animals have to be considered. This also applies to the ethical aspects dealing with the sustainable use of the environment and the protection of human and animal health.</p>
		</td>
			</tr>
			
			<tr>
				<td width="25%" valign="top" class="side">
			
				<p class="side">Author: Eveline Lecoq</p>
				
			 &nbsp;</td>
				<td width="75%" valign="top">
		
			
			
		</td>
			</tr>
			<tr><td width="25%" valign="top" class="side">&nbsp;</td>
				 <td width="75%"valign="top" align="right">&nbsp; <a href="/en/guides/legislation/"><img src="/home.gif" alt="Up" border="0" /></a> <a href="/en/guides/legislation/05"><img src="/back.gif" alt="Back" border="0" /></a></td></tr></table>

<table border="0" cellpadding="3" cellspacing="0" width="100%">
<tr>
<td class="navbar">&copy 2002 <a class="navbar" href="mailto:info@bics.ch">BICS</a> | Last updated 2000-05-09</td>
</tr>
</table>

</body>

</html>

